Armando Gabrielli

10.0k total citations · 1 hit paper
40 papers, 1.4k citations indexed

About

Armando Gabrielli is a scholar working on Pathology and Forensic Medicine, Immunology and Molecular Biology. According to data from OpenAlex, Armando Gabrielli has authored 40 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 12 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Armando Gabrielli's work include Systemic Sclerosis and Related Diseases (19 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Inflammatory Myopathies and Dermatomyositis (5 papers). Armando Gabrielli is often cited by papers focused on Systemic Sclerosis and Related Diseases (19 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Inflammatory Myopathies and Dermatomyositis (5 papers). Armando Gabrielli collaborates with scholars based in Italy, Switzerland and Norway. Armando Gabrielli's co-authors include Enrico V. Avvedimento, Thomas Krieg, Maria Giovanna Danieli, G Danieli, Marco Candela, Antonio Pezone, Christopher P. Denton, Olivieri Fabiola, Antonio Procopio and F.H.J. van den Hoogen and has published in prestigious journals such as Nucleic Acids Research, Blood and Circulation Research.

In The Last Decade

Armando Gabrielli

40 papers receiving 1.4k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inflammation and DNA damage: cause, effect or both

2023 109 citations Antonio Pezone, Olivieri Fabiola et al. Nature Reviews Rheumatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Armando Gabrielli Italy	19	443	366	272	263	251	40	1.4k
Antonio Carletto Italy	22	481 1.1×	170 0.5×	620 2.3×	166 0.6×	797 3.2×	133	2.0k
Christian Sieder Germany	21	284 0.6×	196 0.5×	415 1.5×	294 1.1×	293 1.2×	52	1.4k
Joanna Makowska Poland	21	132 0.3×	337 0.9×	232 0.9×	759 2.9×	488 1.9×	90	2.0k
Khalil El Karoui France	21	233 0.5×	201 0.5×	304 1.1×	66 0.3×	221 0.9×	58	1.6k
F Mignon France	22	205 0.5×	428 1.2×	289 1.1×	222 0.8×	402 1.6×	70	1.9k
Masayuki Yamanouchi Japan	23	182 0.4×	405 1.1×	151 0.6×	127 0.5×	281 1.1×	195	2.1k
Tamer A. Gheita Egypt	27	262 0.6×	244 0.7×	572 2.1×	86 0.3×	1.0k 4.0×	109	2.0k
B. Bottasso Italy	21	150 0.3×	175 0.5×	120 0.4×	127 0.5×	147 0.6×	38	1.5k
Matthew A. Clark United Kingdom	22	222 0.5×	1.2k 3.4×	117 0.4×	185 0.7×	307 1.2×	46	2.2k
Richard P. Polisson United States	19	316 0.7×	166 0.5×	288 1.1×	89 0.3×	1.0k 4.1×	30	1.7k

Countries citing papers authored by Armando Gabrielli

Since Specialization

Citations

This map shows the geographic impact of Armando Gabrielli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armando Gabrielli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armando Gabrielli more than expected).

Fields of papers citing papers by Armando Gabrielli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Armando Gabrielli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armando Gabrielli. The network helps show where Armando Gabrielli may publish in the future.

Co-authorship network of co-authors of Armando Gabrielli

This figure shows the co-authorship network connecting the top 25 collaborators of Armando Gabrielli. A scholar is included among the top collaborators of Armando Gabrielli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Armando Gabrielli. Armando Gabrielli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yinan, Alexandru‐Emil Matei, Andrea‐Hermina Györfi, et al.. (2024). Characterization of Vascular Niche in Systemic Sclerosis by Spatial Proteomics. Circulation Research. 134(7). 875–891. 19 indexed citations

Pezone, Antonio, et al.. (2023). Inflammation and DNA damage: cause, effect or both. Nature Reviews Rheumatology. 19(4). 200–211. 109 indexed citations breakdown →

Hoffmann‐Vold, Anna‐Maria, Chiara Pellicano, A. Romaniello, et al.. (2023). The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort. Autoimmunity Reviews. 22(4). 103290–103290. 19 indexed citations

Guler, Sabina A., Odile Stalder, Yannick Allanore, et al.. (2023). Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysis. Thorax. 78(12). 1188–1196. 15 indexed citations

Hoffmann‐Vold, Anna‐Maria, Oliver Distler, Cosimo Bruni, et al.. (2022). Systemic sclerosis in the time of COVID-19. The Lancet Rheumatology. 4(8). e566–e575. 6 indexed citations

Benfaremo, Devis, Silvia Svegliati, Ada Funaro, et al.. (2022). Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis. Frontiers in Immunology. 13. 1072462–1072462. 7 indexed citations

Zanatta, Elisabetta, Dörte Huscher, Alexandra Balbir‐Gurman, et al.. (2021). POS0318 CLINICAL PHENOTYPE IN SCLERODERMA PATIENTS WITH ANTI-TOPOISOMERASE I POSITIVITY AND LIMITED CUTANEOUS FORM: DATA FROM THE EUSTAR DATABASE. Annals of the Rheumatic Diseases. 80. 386–387. 2 indexed citations

Bruni, Cosimo, Sebastian Heidenreich, Anna‐Maria Hoffmann‐Vold, et al.. (2021). POS0855 PATIENT PREFERENCES, TRADE-OFFS AND ACCEPTABLE RISKS IN THE TREATMENT OF SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A STEP TOWARDS SHARED DECISION-MAKING. Annals of the Rheumatic Diseases. 80. 681–682. 1 indexed citations

Avvedimento, Enrico V. & Armando Gabrielli. (2021). Linking NAD metabolism and DNA repair to inflammation in SSc. Nature Reviews Rheumatology. 17(7). 381–382. 6 indexed citations

10.

Bruni, Cosimo, Leland W.K. Chung, Anna‐Maria Hoffmann‐Vold, et al.. (2021). High-resolution computed tomography of the chest for the screening, re-screening and follow-up of systemic sclerosis-associated interstitial lung disease: a EUSTAR-SCTC survey. Clinical and Experimental Rheumatology. 40(10). 1951–1955. 11 indexed citations

11.

Pezone, Antonio, Maria Letizia Taddei, Alfonso Tramontano, et al.. (2020). Targeted DNA oxidation by LSD1–SMAD2/3 primes TGF-β1/ EMT genes for activation or repression. Nucleic Acids Research. 48(16). 8943–8958. 31 indexed citations

12.

Danieli, Maria Giovanna, et al.. (2018). Potential Anti-Tumor Activity of Intravenous and Subcutaneous Immunoglobulin.. PubMed. 20(12). 782–783. 4 indexed citations

13.

Danieli, Maria Giovanna, et al.. (2017). Subcutaneous IgG in the Myositis Spectrum Disorders. Current Rheumatology Reviews. 14(3). 194–199. 3 indexed citations

14.

Bonifazi, Martina, Francesca Bravi, Stefano Gasparini, et al.. (2014). Sarcoidosis and Cancer Risk. CHEST Journal. 147(3). 778–791. 96 indexed citations

15.

Danieli, Maria Giovanna, et al.. (2014). Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study. Autoimmunity Reviews. 13(10). 1048–1054. 54 indexed citations

16.

Dziadzio, Magdalena, Philip N. Hawkins, Michael Potter, et al.. (2005). From scleredema to AL amyloidosis: disease progression or coincidence? Review of the literature. Clinical Rheumatology. 25(1). 3–15. 15 indexed citations

17.

Chizzolini, Carlo, Elena Raschi, Roger Rezzonico, et al.. (2002). Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis. Arthritis & Rheumatism. 46(6). 1602–1613. 112 indexed citations

18.

Sambo, Paola, Marco Candela, Aldo Salvi, et al.. (1999). Monocytes of Patients with Systemic Sclerosis (Scleroderma) Spontaneously Release In Vitro Increased Amounts of Superoxide Anion. Journal of Investigative Dermatology. 112(1). 78–84. 88 indexed citations

19.

Pioltelli, Pietro, Angelo Vacca, Cesare Mazzaro, et al.. (1996). GISC protocol experience in the treatment of essential mixed cryoglobulinaemia.. PubMed. 13 Suppl 13. S187–90. 8 indexed citations

20.

Galli, Massimo, Giuseppe Monti, F Invernizzi, et al.. (1992). Hepatitis B virus-related markers in secondary and in essential mixed cryoglobulinemias: A multicentric study of 596 cases. 7(4). 209–214. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact